Xia, Ruo-Lan
755  Ergebnisse:
Personensuche X
?
1

Clinical features, treatment, and prognosis of different hi..:

Zhou, Yu-Wen ; Xia, Ruo-Lan ; Chen, Yue-Yun..
European Journal of Surgical Oncology.  47 (2021)  8 - p. 2108-2118 , 2021
 
?
2

Immune checkpoint inhibitor-associated ophthalmic adverse e..:

Zhou, Yu-Wen ; Xu, Qian ; Wang, Yan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995716/.  , 2022
 
?
3

The Pharmacokinetics and Pharmacodynamics of A Novel Recomb..:

Liu, Yu-lu ; Zhu, Xiao-xia ; Niu, Li-yun...
Journal of Pharmaceutical Sciences.  112 (2023)  3 - p. 877-883 , 2023
 
?
 
?
5

Corrigendum: MicroRNA339 Targeting PDXK Improves Motor Dysf..:

Xiong, Liu-Lin ; Qin, Yan-Xia ; Xiao, Qiu-Xia...
Frontiers in Cell and Developmental Biology.  10 (2022)  - p. , 2022
 
?
6

MicroRNA339 Targeting PDXK Improves Motor Dysfunction and P..:

Xiong, Liu-Lin ; Qin, Yan-Xia ; Xiao, Qiu-Xia...
Frontiers in Cell and Developmental Biology.  8 (2020)  - p. , 2020
 
?
 
?
 
?
9

Pharmacokinetics and pharmacodynamics of SCT800, a new reco..:

Gu, Ruo-lan ; Liu, Liang ; Xie, Liang-zhi...
Acta Pharmacologica Sinica.  37 (2016)  3 - p. 408-414 , 2016
 
?
10

Claudin-3 is required for modulation of paracellular permea..:

Mei, Mei ; Xiang, Ruo-Lan ; Cong, Xin...
Cellular Signalling.  27 (2015)  10 - p. 1915-1927 , 2015
 
?
11

Immune checkpoint inhibitor-associated ophthalmic adverse e..:

Yu-Wen Zhou ; Qian Xu ; Yan Wang...
http://ies.ijo.cn/en_publish/2022/4/20220419.pdf.  , 2022
 
?
 
?
13

Heart-targeting exosomes from human cardiosphere-derived ce..:

Mao, Liang ; Li, Yun-Da ; Chen, Ruo-Lan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531502/.  , 2022
 
?
 
?
15

Pharmacokinetics and pharmacodynamics of SCT800, a new reco..:

Gu, Ruo-lan ; Liu, Liang ; Xie, Liang-zhi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775845/.  , 2016
 
1-15
Mehr Literatur finden